These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 20958095

  • 1. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
    Patel S, Chavhan S, Soni H, Babbar AK, Mathur R, Mishra AK, Sawant K.
    J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095
    [Abstract] [Full Text] [Related]

  • 2. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.
    Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K.
    Int J Pharm; 2008 Jun 24; 358(1-2):285-91. PubMed ID: 18455333
    [Abstract] [Full Text] [Related]

  • 3. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
    Qureshi M, Aqil M, Imam SS, Ahad A, Sultana Y.
    Curr Drug Deliv; 2019 Jun 24; 16(2):123-135. PubMed ID: 30317997
    [Abstract] [Full Text] [Related]

  • 4. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J, Wang Q, Zhou X, Zhang N.
    Int J Pharm; 2008 Mar 20; 352(1-2):273-9. PubMed ID: 18054182
    [Abstract] [Full Text] [Related]

  • 5. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
    Silva AC, Kumar A, Wild W, Ferreira D, Santos D, Forbes B.
    Int J Pharm; 2012 Oct 15; 436(1-2):798-805. PubMed ID: 22867992
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nose-to-brain delivery of tacrine.
    Jogani VV, Shah PJ, Mishra P, Mishra AK, Misra AR.
    J Pharm Pharmacol; 2007 Sep 15; 59(9):1199-205. PubMed ID: 17883890
    [Abstract] [Full Text] [Related]

  • 9. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2013 Feb 14; 48(3):393-405. PubMed ID: 23266466
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
    Parikh T, Bommana MM, Squillante E.
    Eur J Pharm Biopharm; 2010 Mar 14; 74(3):442-50. PubMed ID: 19941957
    [Abstract] [Full Text] [Related]

  • 11. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
    Jafarieh O, Md S, Ali M, Baboota S, Sahni JK, Kumari B, Bhatnagar A, Ali J.
    Drug Dev Ind Pharm; 2015 Mar 14; 41(10):1674-81. PubMed ID: 25496439
    [Abstract] [Full Text] [Related]

  • 12. Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin.
    Ruan Y, Yao L, Zhang B, Zhang S, Guo J.
    Drug Dev Ind Pharm; 2012 Jan 14; 38(1):123-8. PubMed ID: 21721852
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):6-15. PubMed ID: 22561106
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
    Wohlfart S, Khalansky AS, Gelperina S, Begley D, Kreuter J.
    J Control Release; 2011 Aug 25; 154(1):103-7. PubMed ID: 21616104
    [Abstract] [Full Text] [Related]

  • 17. Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation.
    Muthu MS, Singh S.
    Nanomedicine (Lond); 2008 Jun 25; 3(3):305-19. PubMed ID: 18510426
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.
    Hu K, Shi Y, Jiang W, Han J, Huang S, Jiang X.
    Int J Pharm; 2011 Aug 30; 415(1-2):273-83. PubMed ID: 21651967
    [Abstract] [Full Text] [Related]

  • 20. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
    Shah B, Khunt D, Misra M, Padh H.
    Int J Biol Macromol; 2016 Aug 30; 89():206-18. PubMed ID: 27130654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.